key: cord-0872733-6jxaugjk authors: Ikeda, Shinichiro; Shih, Michael; Rhee, Robert Y.; Youdelman, Benjamin A. title: Acute complicated type B aortic dissection during the New York City COVID‐19 surge date: 2020-06-04 journal: J Card Surg DOI: 10.1111/jocs.14678 sha: cdf5cfac1f718413fcf472208af7f0a031936a0b doc_id: 872733 cord_uid: 6jxaugjk The impact of the coronavirus disease 2019 (COVID‐19) pandemic in New York City (NYC) is dramatic. COVID‐19 cases surged, hospitals expanded to meet capacity, and NYC remains the global epicenter of this pandemic. During this unprecedented time, a young woman with known Marfan syndrome presented with an acute complicated type B aortic dissection to our Aortic Center. Using the provisional extension to induce a complete attachment technique, we treated this patient and quickly discharged her the next day to decrease the risk of COVID‐19 infection. Her progress was monitored using frequent phone calls and one office visit at two weeks. The impact of the coronavirus disease 2019 (COVID-19) pandemic in New York City is dramatic. COVID-19 cases surged and hospitals expanded to meet the need. Elective surgical cases were canceled due to concern about hospital beds and the risk of perioperative COVID-19 infection. This same concern contributed to the dramatic decrease in non-COVID-19 emergency cases presenting to the hospital which was associated with a dramatic increase in the at-home deaths during this same period (reference is contact with FDNY regarding EMS at-home death findings March-April 2020). During this The rate of spinal cord ischemia after TEVAR is 6% to 10%. 5, 7 In contrast, in the Study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I), favorable results were found with the Zenith Dissection Endovascular System (Cook Medical) with a 30-day paraplegia rate of 1.8%. 6 Less disruption of spinal cord perfusion with the use of bare metal stent, continued FL compression to encourage thrombosis and remodeling. 9 There is limited data on TEVAR/EVAR for patients with MFS and only a few case reports presented PETTICOAT technique for patients with MFS. 8 A study reported that the rate of the primary treatment failure in patients with MFS treated with TEVAR/EVAR was 44% due to endoleaks. 3 We present a patient who is a member of a subset of MFS patients who can benefit from TEVAR as rescue therapy. This was true both because of the clinical presentation and the timing of her presentation during the COVID-19 pandemic surge. If there was a problem that made her unable to be extubated, we would have to stay in the OR on the anesthesia machine until a ventilator was delivered as there was no available ventilator in the hospital. The patient will be followed closely for the need for surgical repair. Rapid TEVAR with the PETTICOAT technique was effective to expand the TL, reperfuse the visceral organs and lower extremities, prevent spinal cord ischemia, and allowed prompt discharge during the COVID-19 pandemic. Standard postoperative protocols were abandoned effectively for patient safety. The authors declare that there are no conflict of interests. Consent for this publication was obtained from the patient. Preoperative computed tomography scan which shows: A, Dissection started at the proximal descending aorta. The TL was significantly compressed by the FL. B, The entry tear was seen in the mid-descending aorta. C, Right kidney flow was diminished as the TL is significantly compressed. D, A flow of the Rt. CIA decreased. FL, false lumen; Rt. CIA, right common iliac artery; TL, true lumen Systematic review and meta-analysis of acute type B thoracic aortic dissection, open, or endovascular repair Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent grafts Endovascular treatment of acute and chronic aortic pathology in patients with Marfan syndrome Aortic endovascular stenting in patients with systemic connective tissue disorders: does the prohibitive dogma still stand tall? Extent of aortic coverage and incidence of spinal cord ischemia after thoracic endovascular aneurysm repair Five-year results from the study of Thoracic Aortic Type B Dissection Using Endoluminal Repair (STABLE I) study of endovascular treatment of complicated type B aortic dissection using a composite device design Report on the results of thoracic endovascular aortic repair for acute complicated type B aortic dissection at 30 days and 1 year from a multidisciplinary subcommittee of the Society for Vascular Surgery Outcomes Committee The PETTICOAT technique for complicated acute ) was deployed into the proximal descending aorta covering the primary tear site (between the red lines). D, The TL was still compressed from the FL through the visceral arteries segment and infrarenal segment with improved visceral perfusion. E, After TEVAR and the distal bare metal stent (between the red lines), the flow of CA and SMA improved. The flow into the FL in the descending aorta disappeared. F, The flow of Rt. RA and Rt. CIA was clearly seen and the left RA was perfused from the FL. CA, celiac artery; FL, false lumen; Rt. CIA, right common iliac artery; Rt. RA, right renal artery; SMA, superior mesenteric artery; TEVAR: thoracic endovascular aortic repair; TL, true lumen stanford type B aortic dissection using a tapered self-expanding nitinol device as distal uncovered stent Aortic remodeling after endovascular repair of complicated acute type B aortic dissection Acute complicated type B aortic dissection during the New York City COVID-19 surge http://orcid.org/0000-0001-8318-9379